Acurx Pharmaceuticals, Inc. (ACXP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 3.73M |
| Enterprise Value | -7.55B |
| P/E Ratio | -0.32 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.33 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.91 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.79 |
| Return On Equity | -1.54 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -7.97M |
| Net Income | -7.97M |
| Diluted EPS | -5.32 |
| Total Cash | 9.25M |
| Total Cash/Share | 6.17 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.78 |
| Book Value Per Share | 4.68 |
| 52-Week Change | -87.14 |
| 52-Week High | 12.64 |
| 52-Week Low | 1.33 |
| Moving Average 50 Days | 2.03 |
| Moving Average 200 Days | 3.41 |
| Average Volume | 160,877 |
| Shares Outstanding | 1.58M |
| % Held by Institutions | 6.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | August 05, 2025 |